← Leaderboards
Kamel Belkacem-Boussaid
Kestrel Corporation
$160,034
Attributed
$160,034
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $100.1K · FY2006–07$200K$150K$100K$50K$0
'06
'07
Funding mix
By agency
NIH$160,034 · 1
By mechanism
R43$160,034 · 1
Top collaborators
No co-investigators on record.
Most similar at Kestrel Corporation
Same institution · by research overlap
- Peter N Soliz$3,132,540
- Gilberto Zamora$1,304,342
- Gavin Erry$593,222
- Mark P Wilson$205,826
- L John Otten$105,900
Others in their field
Top investigators on “Age Related Macular Degeneration”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Rohit Varma · University Of Southern California$50,124,787
- Maureen G Maguire · University Of Pennsylvania$38,506,792
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Krzysztof Palczewski · University Of California-Irvine$27,513,979
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
Age Related Macular DegenerationAlgorithmsBaseBlindBlurClinicClinically SignificantClinical ResearchColorComputer SoftwareConceptConditionConditioningCostDevicesDiabetic RetinopathyDiagnosis, ClinicalDiagnosticDigitalDoctor Of PhilosophyElectronicsEntropyEnvironmentAdaptive Optics